Skip to main content Accessibility help
×
Home

Abnormal myocardial blood flow in children with mild/moderate aortic stenosis

  • Erin Madriago (a1), Ronald Wells (a1), David J. Sahn (a1), Brian S. Diggs (a2), Stephen M. Langley (a1) (a2), Daniel J. Woodward (a3), Michael Jerosch-Herold (a4) and Michael Silberbach (a1)...

Abstract

Objective

To quantify myocardial blood flow in infants and children with mild or moderate aortic stenosis using adenosine-infusion cardiac magnetic resonance.

Background

It is unclear whether asymptomatic children with mild/moderate aortic stenosis have myocardial abnormalities. In addition, cardiac magnetic resonance-determined normative myocardial blood flow data in children have not been reported.

Methods

We studied 31 infants and children with either haemodynamically normal hearts (n=20, controls) or mild/moderate aortic stenosis (n=11). The left ventricular myocardium was divided into six segments, and the change in average segmental signal intensity during contrast transit was used to quantify absolute flow (ml/g/minute) at rest and during adenosine infusion by deconvolution of the tissue curves with the arterial input of contrast.

Results

In all the cases, adenosine was well tolerated without complications. The mean pressure gradient between the left ventricle and the ascending aorta was higher in the aortic stenosis group compared with controls (24 versus 3 mmHg, p<0.001). Left ventricular wall mass was slightly higher in the aortic stenosis group compared with controls (65 versus 50 g/m2, p<0.05). After adenosine treatment, both the absolute increase in myocardial blood flow (p<0.0001) and the hyperaemic flow significantly decreased (p<0.001) in children with mild/moderate aortic stenosis compared with controls.

Conclusion

Abnormal myocardial blood flow in children with mild/moderate aortic stenosis may be an important therapeutic target.

Copyright

Corresponding author

Correspondence to: Dr Michael Silberbach, MD, Division of Pediatric Cardiology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States of America. Tel: +(503) 494-2192; Fax +(503) 418-5793; E-mail: silberbm@ohsu.edu

References

Hide All
1. Azevedo, CF, Nigri, M, Higuchi, ML, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 2010; 56: 278287.
2. Weidemann, F, Herrmann, S, Stork, S, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009; 120: 577584.
3. Flett, AS, Sado, DM, Quarta, G, et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 2012; 13: 819826.
4. Marcus, ML, Harrison, DG, Chilian, WM, et al. Alterations in the coronary circulation in hypertrophied ventricles. Circulation 1987; 75: I19I25.
5. Constantine, G, Shan, K, Flamm, SD, Sivananthan, MU. Role of MRI in clinical cardiology. The Lancet 2004; 363: 21622171.
6. Wang, L, Jerosch-Herold, M, Jacobs, DR Jr, Shahar, E, Folsom, AR. Coronary risk factors and myocardial perfusion in asymptomatic adults: the multi-ethnic study of atherosclerosis (mesa). J Am Coll Cardiol 2006; 47: 565572.
7. Kramer, CM, Barkhausen, J, Flamm, SD, Kim, RJ, Nagel, E. Standardized cardiovascular magnetic resonance imaging (cMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008; 10: 35.
8. Jerosch-Herold, M, Seethamraju, RT, Swingen, CM, Wilke, NM, Stillman, AE. Analysis of myocardial perfusion MRI. J Magn Reson Imaging 2004; 19: 758770.
9. Petersen, SE, Jerosch-Herold, M, Hudsmith, LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007; 115: 24182425.
10. Team RDC. R: A language and environment for statistical computing (http://www.R-project.Org/). R Foundation for Statistical Computing; Institute for Statistics and Mathematics, Wirtschaftsuniversität Wien Welthandelsplatz 1, Vienna, Austria, 2010.
11. Roccella, E. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555576.
12. Jahnke, C, Nagel, E, Gebker, R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007; 115: 17691776.
13. Chareonthaitawee, P, Kaufmann, PA, Rimoldi, O, Camici, PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001; 50: 151161.
14. Rosen, BD, Lima, JA, Nasir, K, et al. Lower myocardial perfusion reserve is associated with decreased regional left ventricular function in asymptomatic participants of the multi-ethnic study of atherosclerosis. Circulation 2006; 114: 289297.
15. Puchalski, MD, Williams, RV, Askovich, B, et al. Late gadolinium enhancement: precursor to cardiomyopathy in duchenne muscular dystrophy? Int J Cardiovasc Imaging 2009; 25: 5763.
16. Wicker, P, Tarazi, RC. Coronary blood flow in left ventricular hypertrophy: a review of experimental data. Eur Heart J 1982; 3 (Suppl A): 111118.
17. Hoffman, JI. Problems of coronary flow reserve. Ann Biomed Eng 2000; 28: 884896.
18. Rakusan, K, Flanagan, MF, Geva, T, Southern, J, Van Praagh, R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 1992; 86: 3846.
19. Feldman, AM, Cheksis-Feiner, E, Hamad, E, Chan, T. Adenosine receptor subtypes and the heart failure phenotype: translating lessons from mice to man. Trans Am Clin Climatol Assoc 2011; 122: 198214.
20. Funabiki, K, Onishi, K, Dohi, K, et al. Combined angiotensin receptor blocker and ace inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure. Am J Physiol Heart Circ Physiol 2004; 287: H2487H2492.
21. Hudson, MP, Armstrong, PW, Ruzyllo, W, et al. Effects of selective matrix metalloproteinase inhibitor (pg-116800) to prevent ventricular remodeling after myocardial infarction: results of the premier (prevention of myocardial infarction early remodeling) trial. J Am Coll Cardiol 2006; 48: 1520.
22. Kaye, DM, Krum, H. Drug discovery for heart failure: a new era or the end of the pipeline? Nature reviews . Drug Disc 2007; 6: 127139.
23. Sata, Y, Krum, H. The future of pharmacological therapy for heart failure. Circ J 2010; 74: 809817.
24. Young, MJ, Lam, EY, Rickard, AJ. Mineralocorticoid receptor activation and cardiac fibrosis. Clin Sci (Lond) 2007; 112: 467475.
25. Dietrich, O, Reiser, MF, Schoenberg, SO. Artifacts in 3-T MRI: physical background and reduction strategies. Eur J Radiol 2008; 65: 2935.
26. Berry, C, Balachandran, KP, L’Allier, PL, Lesperance, J, Bonan, R, Oldroyd, KG. Importance of collateral circulation in coronary heart disease. Eur Heart J 2007; 28: 278291.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed